A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer
暂无分享,去创建一个
B. Ramaswamy | C. Shapiro | X. Pan | S. Puhalla | M. Lustberg | S. Carothers | Erin R. Macrae | R. Wesolowski | R. Layman | E. Mrózek | Meng Zhao